Acute bleeding after allogeneic bone marrow transplantation: Association with graft versus host disease and effect on survival

Transplantation

Volumn 67, Issue 5, 1999, Pages 681-689

  Nevo, Shoshan ^a   Enger, Cheryl ^a   Swan, Valerie ^a   Wojno, Kirk J ^b   Fuller, Alice K ^a   Altomonte, Viki ^a   Braine, Hayden G ^a   Noga, Stephen J ^a   Vogelsang, Georgia B ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLEEDING; CHILD; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL;

EID: 0033558995     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903150-00007     Document Type: Article

References (50)

1. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295.
2. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Consensus Development Conference. Bone Marrow Transplant 1995; 15: 825.
3. Shuhart MC, McDonald GB. Gastrointestinal and hepatic complications. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplant. Cambridge, MA: Blackwell Scientific Publications, 1994: 454.
4. Wolford JL, Mcdonald GB. Gastrointestinal bleeding after marrow transplant: a prospective study of risk factors, etiology, and outcome [Abstract]. Gastroenterology 1987; 92: 1697.
5. Ost L, Lonnqvist B, Eriksson L, Ljungman P, Ringden O. Hemorrhagic cystitis - a manifestation of graft versus host disease?. Bone Marrow Transplant. 1987; 2: 19.
6. Russell SJ, Vowels MR, Vale T. Haemorrhagic Cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533.
7. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Transplantation 1993; 56: 875.
8. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103.
9. Turkeri LN, Lum LG, Uberti JP, et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol 1995; 153(3 Pt 1): 637.
10. Schiller GJ, Gale RP. A critical reappraisal of gastrointestinal complications of allogeneic bone marrow transplantation. Cell Transplant 1992; 1: 265.
11. Vogelsang GB, Hess AD, Santos GW. Acute graft-versus-host disease: clinical characteristics in the cyclosporine era. Medicine 1988; 67: 163.
12. Joachim DH, Cottler Fox M. Clinical Spectrum and pathophysiology of acute graft-vs.-host-disease. In: Burakoff SJ, Deeg JH, Ferrara J, Atkinson K, eds. Graft-vs.-host-disease immunology, pathophysiology, and treatment (Hematology; Vol.12). New York: Marcel Dekker Inc, 1990: 311.
13. Marcellus DC, Vogelsang GB. Graft-versus-host disease. Curr Opin Oncol 1997; 9:131.
14. Wojno KJ, Vogelsang GB, Beschorner WE, Santos GW. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation 1994; 57: 88.
15. Agusti C, Ramirez J, Picado C, et al. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation, A postmortem study. Am J Respir Crit Care Med 1995; 151: 1006.
16. Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983; 308: 302.
17. Gratwohl A, Hermans J, Apperley J, et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia, Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 1995; 86: 813.
18. Rowlings PA, Przepiorka D, Klein JP, Horowitz MM, Bortin MM. Heterogeneity of outcome between and within grades of acute Graft Versus Host disease (AGVHD) [Abstract]. Exp Hematol 1994; 22: 680.
19. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855.
20. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) - incidence and effect on survival. A quantitative analysis in 1402 patients. Blood 1998; 3: 1469
21. Noga SJ, Vogelsang GB, Seber A, et al. CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity. Transplant Proc 1997; 29: 728.
22. Miller CB, Piantadosi S, Vogelsang GB, et al: Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol 1996; 14:1327.
23. May WS, Sensenbrenner LL, Burns WH, et al. Bone marrow transplantation for severe aplastic anemia using cyclostpoine A. Bone Marrow Transplant 1993; 11: 459.
24. Lazarus HM, Vogelsang GB, Rowe JM. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant 1997; 19: 577.
25. Vogelsang GB, Wolff D, Altomonte V, et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
27. Cox DR, Oakes D. Analysis of survival data. London, England: Chapman & Hall Ltd., 1984.
28. Ruutu T, Ruutu M, Volin L, Leskinen R. Severe cystitis as a manifestation of chronic graft-versus-host disease after bone marrow transplantation. Br J Urol 1988; 62: 612.
29. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994; 14 (suppl 4): S19.
30. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
31. Barrett AJ. Graft-versus-host disease: a review. J R Soc Med 1987; 80:368.
32. Beschorner WE, Shinn CA, Hess AD, Suresch DL, Santos GW. Immune-related injury to endothelium associated with acute graft-versus-host disease in the rat. Transplant Proc 1989; 21: 3025.
33. Dumler JS, Beschorner WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol 1989; 135: 1097.
34. Saito H, Oshimi K, Nagasako K, et al. Endoscopic appearance of the colon and small intestine of a patient with hemorrhagic enteric graft-vs.-host disease. Dis Colon Rectum 1990; 33: 695.
35. Shabahang M, Pasquale MD, Bitterman P, Cirenza E, Spitzer T, Evans SR. Massive hematochezia secondary to graft-versus-host disease and cytomegalovirus. Am J Gastroenterol 1994; 89: 632.
36. Srivastava A, Gottlieb D, Bradstock KF. Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 863.
37. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996; 47: 315.
38. Salat C, Holler E, Kolb HJ, Pihusch R, Reinhardt B, Hiller E. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant 1997; 19: 909.
39. Olle R. Viral infections and graft-vs.-host-disease. In: Burakoff SJ, Deeg JH, Ferrara J, Atkinson K (eds): Graft-vs.-host-disease immunology, pathophysiology, and treatment (Hematology; Vol.12). New York: Marcel Dekker Inc, 1990: 467.
40. Blanke C, Clark C, Broun ER, et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med 1995; 99: 326.
41. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964.
42. Vogelsang GB. Graft-versus-host disease: implications from basic immunology for prophylaxis and treatment. Cancer Treat Res 1997; 77: 87.
43. Colin-Jones DG. Drug-induced gastrointestinal ulceration: a review. J R Soc Med 1980; 73:46.
44. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054.
45. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985; 65: 368.
46. Bierling P, Cordonnier C, Fromont P, et al. Acquired autoimmune thrombocytopenia after allogeneic bone marrow transplantation. Br J Haematol 1985; 59: 643.
47. Cahn JY, Chabot J, Esperou H, Flesch M, Plouvier E, Herve P. Autoimmune-like thrombocytopenia after bone marrow transplantation [Letter]. Blood 1989; 74: 2771.
48. Apperley JF, Rice SJ, Bishop JA, et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 1987; 43: 108.
49. Fox RJ, Vogelsang GB, Beschorner WE. Denuded bowel after recovery from graft-versus-host disease. Transplantation 1996; 62: 1681.
50. Nevo S, Enger C, Swan V, Fuller AK, Briane HG, Vogelsang GB. The incidence and timing pattern of acute gastrointestinal hemorrhage in autologous and allogeneic bone marrow transplantation (BMT) [Abstract]. Blood 1997; 90 (suppl 2): 4428.